Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care

Clinical trial NCT03420430 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03420430
Sponsor: Genelux Corporation
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Advanced Stage Cancer (Solid Tumor Disease for 4 Patients)Acute Myeloid Leukemia (6 Patients)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.